Tissue therapies posts small loss
By Renate Krelle
Thursday, 10 February, 2005
Thursday, 10 February, 2005
Tissue Therapies Limited (ASX:TIS) has released its half-year results, recording a net loss of $445,400, in line with budget expectations.
At December 31, the company had cash reserves of almost $4 million, bolstered by a $1.5 million capital raising in October last year.
It spent $524,000 on research and development, and banked revenue of $152,5000 from research grants and interest.
Related News
Scientists uncover how cancer cells hide from immune system
By targeting the RNA helicase known as DDX6, scientists could enable the immune system to...
Vanillin flavouring in vapes may disrupt embryo development
Vanillin — a common flavouring chemical in e-cigarettes — may disrupt the normal...
Heart valve tissues created from stem cells
The breakthrough should help advance our understanding into how human heart valves develop,...
